JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alt, A.
Right arrow Articles by Traynor, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alt, A.
Right arrow Articles by Traynor, J. R.

Vol. 298, Issue 1, 116-121, July 2001

Stimulation of Guanosine-5'-O-(3-[35S]thio)triphosphate Binding in Digitonin-Permeabilized C6 Rat Glioma Cells: Evidence for an Organized Association of µ-Opioid Receptors and G Protein

Andrew Alt, Iain J. McFadyen, Charles D. Fan, James H. Woods and John R. Traynor

Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan

The guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPgamma S) binding assay for the determination of relative opioid efficacy has been adapted to measure G protein activation in digitonin-permeabilized C6 rat glioma cells expressing a cloned µ-opioid receptor. The µ-agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) caused a 3-fold increase in [35S]GTPgamma S binding over basal in a naloxone-sensitive manner. Relative µ-agonist efficacy was DAMGO > fentanyl >=  morphine > buprenorphine. Nalbuphine showed no efficacy. G protein activation by receptors has been predicted to occur by random encounter. In this model a reduction in the number of receptors will decrease the rate of G protein activation but not the maximum number of G proteins activated. To test this model C6 µ cells were treated with the irreversible µ-antagonist beta -funaltrexamine (10 nM) prior to permeabilization. This reduced the number of µ-opioid receptors determined with [3H]diprenorphine to 23 ± 3% of control with no change in affinity. A commensurate reduction (to 29 ± 10% of control) in the level of [35S]GTPgamma S binding stimulated by DAMGO was observed, but the t1/2 for [35S]GTPgamma S binding remained unchanged. Thus, random encounters of receptor and G protein failed to occur in this permeabilized cell preparation. A model that assumes an organized association of G proteins with receptors better describes the activation of G proteins by opioid µ-receptors.


0022-3565/01/2981-0116$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. L. Roman, J. N. Talbot, R. A. Roof, R. K. Sunahara, J. R. Traynor, and R. R. Neubig
Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay
Mol. Pharmacol., January 1, 2007; 71(1): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. A. Walker, M. J. Picker, A. Granger, and L. A. Dykstra
Effects of Opioids in Morphine-Treated Pigeons Trained to Discriminate among Morphine, the Low-Efficacy Agonist Nalbuphine, and Saline
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 150 - 158.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. A. Martin, M. B. Ruckle, S. L. VanHoof, and P. L. Prather
Agonist, Antagonist, and Inverse Agonist Characteristics of TIPP (H-Tyr-Tic-Phe-Phe-OH), a Selective delta -Opioid Receptor Ligand
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 661 - 671.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.